Search research articles
Contact Us
Filters
Showing results (81-90 of 188) with videos related to
Page
of 19
Sort By:
Autonomic Neuroscience : Basic & Clinical
|
September 22, 2022
Preferential impairment of parasympathetic autonomic function in type 2 diabetes
Thorsten K Rasmussen, Nanna B Finnerup, Wolfgang Singer, et al.
Journal of Medical Internet Research
|
April 6, 2016
Cardiac Patients' Walking Activity Determined by a Step Counter in Cardiac Telerehabilitation: Data From the Intervention Arm of a Randomized Controlled Trial
Charlotte Thorup, John Hansen, Mette Grønkjær, et al.
Open Forum Infectious Diseases
|
July 4, 2020
Safety of Recombinant Influenza Vaccine Compared to Inactivated Influenza Vaccine in Adults: An Observational Study
John Hansen, Kristin Goddard, Julius Timbol, et al.
Human Vaccines & Immunotherapeutics
|
July 9, 2016
Post-licensure safety surveillance study of routine use of tetanus toxoid, reduced diphtheria toxoid and 5-component acellular pertussis vaccine
Roger Baxter, John Hansen, Julius Timbol, et al.
Vaccine
|
September 12, 2012
Safety of Zostavax™--a cohort study in a managed care organization
Roger Baxter, Trung Nam Tran, John Hansen, et al.
Nutrients
|
September 14, 2024
Implementing a Diet Risk Score (DRS) for Spanish-Speaking Adults in a Clinical Setting: A Feasibility Study
Emily A Johnston, Maria Torres, John Hansen, et al.
The European Respiratory Journal
|
March 30, 2023
Hiding in plain sight: the evolving definition of chronic breathlessness and new ICD-11 wording
Slavica Kochovska, Magnus Ekström, John Hansen-Flaschen, et al.
Vaccine
|
July 5, 2016
Safety of DTaP-IPV/Hib vaccine administered routinely to infants and toddlers
John Hansen, Julius Timbol, Ned Lewis, et al.
The European Respiratory Journal
|
May 27, 2017
Towards an expert consensus to delineate a clinical syndrome of chronic breathlessness
Miriam J Johnson, Janelle Yorke, John Hansen-Flaschen, et al.
Vaccine
|
February 12, 2013
A postlicensure evaluation of the safety of Ann Arbor strain live attenuated influenza vaccine in children 24-59 months of age
Seth L Toback, Christopher S Ambrose, Abigail Eaton, et al.
Page
of 19
Search research articles
Search
Showing results (81-90 of 188) with videos related to
Sort By:
Page
of 19
Autonomic Neuroscience : Basic & Clinical
|
September 22, 2022
Preferential impairment of parasympathetic autonomic function in type 2 diabetes
Thorsten K Rasmussen, Nanna B Finnerup, Wolfgang Singer, et al.
Journal of Medical Internet Research
|
April 6, 2016
Cardiac Patients' Walking Activity Determined by a Step Counter in Cardiac Telerehabilitation: Data From the Intervention Arm of a Randomized Controlled Trial
Charlotte Thorup, John Hansen, Mette Grønkjær, et al.
Open Forum Infectious Diseases
|
July 4, 2020
Safety of Recombinant Influenza Vaccine Compared to Inactivated Influenza Vaccine in Adults: An Observational Study
John Hansen, Kristin Goddard, Julius Timbol, et al.
Human Vaccines & Immunotherapeutics
|
July 9, 2016
Post-licensure safety surveillance study of routine use of tetanus toxoid, reduced diphtheria toxoid and 5-component acellular pertussis vaccine
Roger Baxter, John Hansen, Julius Timbol, et al.
Vaccine
|
September 12, 2012
Safety of Zostavax™--a cohort study in a managed care organization
Roger Baxter, Trung Nam Tran, John Hansen, et al.
Nutrients
|
September 14, 2024
Implementing a Diet Risk Score (DRS) for Spanish-Speaking Adults in a Clinical Setting: A Feasibility Study
Emily A Johnston, Maria Torres, John Hansen, et al.
The European Respiratory Journal
|
March 30, 2023
Hiding in plain sight: the evolving definition of chronic breathlessness and new ICD-11 wording
Slavica Kochovska, Magnus Ekström, John Hansen-Flaschen, et al.
Vaccine
|
July 5, 2016
Safety of DTaP-IPV/Hib vaccine administered routinely to infants and toddlers
John Hansen, Julius Timbol, Ned Lewis, et al.
The European Respiratory Journal
|
May 27, 2017
Towards an expert consensus to delineate a clinical syndrome of chronic breathlessness
Miriam J Johnson, Janelle Yorke, John Hansen-Flaschen, et al.
Vaccine
|
February 12, 2013
A postlicensure evaluation of the safety of Ann Arbor strain live attenuated influenza vaccine in children 24-59 months of age
Seth L Toback, Christopher S Ambrose, Abigail Eaton, et al.
Page
of 19